Fig. 2
From: Role of T cell metabolism in brain tumor development: a genetic and metabolic approach
A forest plot of the six sets of plasma metabolites exhibiting “T cell phenotype-malignant brain tumors” mediating effects. OR, odds ratio; CI, confidence interval. (A) CD28 − CD8 + T cell % CD8 + T cell-5-dodecenoate (12:1n7) /Arachidonate (20:4n6)/Glycerol to glycerol 3-phosphate ratio-malignant brain tumors. (B) Naïve CD8 + T cell %T cell-Octadecanedioylcarnitine (C18-DC)/Eicosanedioate (C20-DC)-malignant brain tumors. (C) Secreting CD4 regulatory T cell Absolute Count-17alpha-hydroxypregnanolone glucuronide-malignant brain tumors. (D) Naïve CD8 + T cell Absolute Count-Octadecanedioylcarnitine (C18-DC)/Eicosanedioate (C20-DC)-malignant brain tumors. (E) CD127- CD8 + T cell Absolute Count-Tyrosine/Glyco-beta-muricholate-malignant brain tumors. (F) HLA_DR_on_HLA_DR+_CD8+_T_cell-Glyco-beta-muricholate-malignant brain tumors